【摘要】 以联合检测晚期肺癌明水中TBP、CEA和TSA变化对临床治疗进行动态观察，结果62例病人有85．48％的TBP阳性率在出现明显疗效时降为32．26％；CEA和TSA水平也分别由治疗前的26．69μg／L、32.35μg／L和583．42mg／L、559．18mg／L降至6．21μg／L、8．44μg／L和349．64mg／L、396．29mg／L。因此认为三项指标的联合检测可以监测晚期肺癌的临床治疗，对经治医生适时地调整治疗方案有一定的指导作用。更多还原

【Abstract】 Sixty-two patients with advanced lung cancer were dynamlcally monitored by determination of tumor basic proteln (TBP), carcinoembryonlc antigen (CEA) and total sialic acid (TSA ) in pleural effusion of the patients. The results showed that the poslt1ve rate of TBP of all the patients reduced from 85. 48 %to 32. 26 % when prominent therapeutic effect was achieved. The levels of CEA and TSA markedly lowered after treatment. The study suggests that comblned determination of TBP, CEA and TSA can he used to monitor the therapeutic effects of advanced lung cancer.更多还原